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Cosmetic Medicine
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Clifford P. Clark III, MD; and Ashley Goldston, LE

Editorial Decision date: September 9, 2020; online publish-ahead-of-print September 23, 2020.

Facial rejuvenation has evolved to include much more than
surgery, with nonsurgical treatments becoming both an adjunct to surgery and the central focus for many patients.
However, the evidence of efficacy for these treatments can
vary widely. Injectables, lasers, and energy-based devices
are brought to market only after vigorous clinical study to
achieve FDA approval. Most of the topical skin therapy, or
skincare, has eluded these norms. These “cosmeceuticals,”
by definition, are the intersection of a drug and a cosmetic.
By design, the industry has enjoyed the nonscientific
benchmarks and regulatory environment of a cosmetic
while asserting a drug’s biologic activity.1 Evidence-based
use of cosmeceuticals can, therefore, be challenging.
The author of “Cosmeceuticals: The Principles and
Practice of Skin Rejuvenation of Nonprescription Topical
Therapy” 2 attempts to bring scientific rationale to our
cosmeceutical skin treatment strategies. The section on
the pathophysiology of skin aging and the physiology
of skin repair is excellent. These principles should establish the foundation of any treatment strategy. The
author’s more challenging goal is to provide a context
in which cosmeceuticals can be clinically utilized. Their
approach organizes the products by the mechanism of
action: tissue repair, immune response modulation, or
antioxidant function. This approach makes sense, and
the authors do an excellent job of summarizing the
products’ mechanism of action within each category.
Unfortunately, the author reaches a similar conclusion
for most of the products: the evidence for efficacy is

limited. Previous authors suggest guidelines to base
our product evaluations: Does the product penetrate
the stratum corneum? Is there a plausible biochemical mechanism of action? Are there published peerreviewed, double-blinded, placebo-controlled trials to
substantiate the efficacy claim?3 Most of the products
except tretinoin,4 and alpha-hydroxy acids,5 fall woefully
short of these criteria.
The paper’s title suggests that the authors will address
the practice of skin rejuvenation with topical therapy.
However, the paper does not help the reader in the
practical formulation of a skincare program with cosmeceuticals. It would have been helpful for the authors to
address the practical aspects of a clinical strategy: How
do we best choose from the universe of productions for a
given patient? How does the patient’s pigmentation, sebaceous content, and pathology guide the selection of
products?6 A patient’s subtle observations of irritation,
the tactile compatibility of products, the complexity of
product application, and lifestyle “fit” are essential, yet
subjective contributions to a treatment’s success and
also need to be addressed.
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The clinical application of a cosmeceutical treatment
plan requires attention to numerous details, many of which
are frustrating to physicians. A cosmetic and cosmeceutical patient history is time-consuming and keeping up with
“trending” products requires constant review. New brands
and products are launched rapidly and aggressively promoted on social media, resulting in a tendency for patients
to worship novelty rather than focus on long-term success.
Working with a licensed aesthetician and other skincare
professionals can provide a team that more effectively relates to the patient and takes the necessary time to engage, educate, and construct a skincare plan that reflects
the patient’s individual needs.
Significant advances have been made in skin rejuvenation, with topical therapy playing an important role.
However, separating fact from fiction with cosmeceuticals continues to be a challenge.7 Understanding the
science of skin aging and repair is an essential component of clinical practice and the authors contribute to our
further understanding. The various products’ theoretic
mechanism of action provides context, but as the authors conclude, the lack of studies limit evidence-based
product selection. An effective treatment plan requires
the analysis of numerous patient and product characteristics that are still mostly learned through trial and
error. These complexities and limitations make effective
topical skin rejuvenation challenging to achieve and a
greater challenge to teach.
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